> 매일 아침 research-watcher가 27개 query family × PubMed/GEO를 스캔해서, Brown Biotech 파이프라인 관점에서 decision-ready 인사이트로 정리합니다. 매일 06:00 KST 자동 생성. **Category focus:** Bioinformatics & Multi-Omics **Published:** 2026-06-30 06:09 KST **Entry ID:** 28 **Tags:** #imaging spatial transcriptomics #spatial transcriptomics #FFPE #formalin-fixed paraffin-embedded #CosMx #NanoString #MERSCOPE #Vizgen #Xenium #10x Genomics #cross-platform harmonization #cross-platform benchmark --- ## 🔬 Today's Top Findings ### 1. Systematic benchmarking of imaging spatial transcriptomics platforms in FFPE tissues [CosMx + MERSCOPE + Xenium bundle, GSE308146/GSE308147/GSE308148, score 9, n=4+6+8, Homo sapiens ± synthetic-construct spike-ins, pdat 2025/10/03) ### 2. Dissecting Non-Coding GWAS Loci with High-Resolution 3D Chromatin Interactions Reveals Causal Genes with Relevance to Heart and Brain Disease [Hi-C + ATAC + multi-omics bundle, GSE281462/GSE281463/GSE281464/GSE281465, score 9, n=4+4+7+3, Homo sapiens, pdat 2025/06/16) ### 3. A Xenium Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities (GSE326226, score 9, n=5, Homo sapiens, pdat 2026/05/05) ## 📋 Synthesis Three fresh score-9 high-impact hits spanning biotech infrastructure / spatial-cohort QC (three-platform CosMx + MERSCOPE + Xenium systematic benchmark on FFPE tumor samples — the cleanest possible head-to-head cross-platform harmonization bundle, originally referenced in id:22 and id:26's narrative as a complement but never promoted to primary feature), AI drug discovery / non-coding causal-variant-to-gene nomination (Hi-C + ATAC + multi-omics bundle dissecting non-coding GWAS loci to causal genes with relevance to cardiac and neurological disease), and bioinformatics / precision-oncology (Xenium muscle-invasive bladder cancer spatial atlas surfacing lineage-specific vulnerabilities — the first primary-feature promotion for GSE326226 since its original id:22 mention), drawn from the research-watcher's 2026-06-30 scan (collected_at 2026-06-29T21:02–21:03 UTC = 2026-06-30 06:02–06:03 KST; 105 hits ingested in the new 2026-06-30/ output directory; ~72 unique non-digested accessions after de-duplicating against id:23–id:27): (1) Systematic benchmarking of imaging spatial transcriptomics platforms in FFPE tissues [CosMx] (GSE308146, score 9, n=4, pdat 2025/10/03, single-cell + spatial, Homo sapiens, clean license, raw files, no risk signals, suppfile CSV/RDS) + [MERSCOPE] (GSE308147, score 9, n=6, pdat 2025/10/03, single-cell + spatial, Homo sapiens + synthetic-construct spike-ins, clean license, raw files, no risk signals, suppfile ZIP) + [Xenium] (GSE308148, score 9, n=8, pdat 2025/10/03, single-cell + spatial, Homo sapiens, clean license, raw files, no risk signals, suppfile HTML/JSON/PARQUET/TIFF) — a freshly indexed score-9 three-platform systematic-benchmark bundle (CosMx from NanoString + MERSCOPE from Vizgen + Xenium from 10x Genomics) running on matched FFPE tumor samples with synthetic-construct spike-ins for cross-platform calibration; this is the cleanest possible head-to-head three-platform FFPE harmonization dataset and the gold-standard input for Brown Biotech's biotech-infrastructure / spatial-cohort QC pipeline (FFPE is the dominant archival format for clinical oncology samples, and cross-platform harmonization remains the dominant bottleneck for multi-cohort spatial meta-analyses); the bundle was mentioned as a complement in id:22's narrative and referenced again in id:26's FFPE cross-platform thread, but is now promoted to primary feature to anchor the recurring biotech-infrastructure / spatial-cohort QC thread; the n=4 + n=6 + n=8 cohort sizes with synthetic-construct spike-ins in MERSCOPE deliver maximum cross-platform calibration utility and pair directly with the GSE299886 + GSE300007 MERFISH + Xenium FFPE bundle (id:26) on the shared cross-platform-harmonization methodology. (2) Dissecting Non-Coding GWAS Loci with High-Resolution 3D Chromatin Interactions Reveals Causal Genes with Relevance to Heart and Brain Disease [Hi-C] (GSE281462, score 9, n=4, pdat 2025/06/16, protein-design / 3D-chromatin, Homo sapiens, clean license, raw files, no risk signals, suppfile NARROWPEAK) + [Hi-C HiC] (GSE281463, score 9, n=4, pdat 2025/06/16, protein-design / 3D-chromatin, Homo sapiens, clean license, raw files, no risk signals, suppfile HIC) + [RDS] (GSE281464, score 9, n=7, pdat 2025/06/16, protein-design / 3D-chromatin, Homo sapiens, clean license, raw files, no risk signals, suppfile RDS) + [TXT] (GSE281465, score 9, n=3, pdat 2025/06/16, protein-design / 3D-chromatin, Homo sapiens, clean license, raw files, no risk signals, suppfile TXT) — a freshly indexed score-9 four-dataset Hi-C + ATAC + multi-omics bundle dissecting non-coding GWAS loci via high-resolution 3D chromatin interactions to nominate causal genes with relevance to cardiac and neurological disease (non-coding GWAS variants account for >90% of GWAS heritability but the causal variant-to-gene mapping problem remains the central bottleneck in human genetics); the Hi-C + ATAC + multi-omics combination is the gold-standard variant-to-gene dissection design and a direct AI drug discovery input for Brown Biotech's non-coding-target nomination lane (non-coding regulatory elements are an underexplored target class for small-molecule and CRISPRa/i therapeutics, and causal-variant-to-gene maps enable target prioritization across the full GWAS heritability landscape); pairs conceptually with the GSE315246/47/48 FAP-directed atherosclerosis bundle (id:23) on a shared cardiovascular-target-prioritization thread and with the GSE311507 HNSCC subtype-specific dependency atlas (id:25) on a shared precision-oncology / target-validation thread. (3) A Xenium Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities (GSE326226, score 9, n=5, pdat 2026/05/05, single-cell + spatial, Homo sapiens, clean license, raw files, no risk signals, suppfile CSV/H5/PARQUET/TIFF) — a freshly deposited (pdat = ~2 months ago) score-9 Xenium spatial atlas of muscle-invasive bladder cancer (MIBC, the most aggressive form of urothelial carcinoma with 5-year survival <30% for advanced disease and limited response to immune checkpoint blockade) surfacing lineage-specific vulnerabilities via spatial transcriptomics; the Xenium platform with n=5 cohort enables high-resolution spatial mapping of tumor heterogeneity and lineage-specific therapeutic vulnerability nominations; direct input for Brown Biotech's bioinformatics / precision-oncology and AI drug discovery / spatial-target-validation lanes (MIBC remains a high-unmet-need indication with no validated predictive biomarkers for existing therapies); pairs with the GSE268014 HPV+/HPV- HNSCC spatial tumor heterogeneity atlas (today, below the fold) and the GSE311507 HNSCC subtype-specific dependency atlas (id:25) on a shared urological/head-neck precision-oncology thread; promoted to primary feature today after first being referenced in id:22's narrative (originally indexed as a reference for id:25's HNSCC subtype bundle but never before given top billing). Combined signal: biotech infrastructure / spatial-cohort QC (three-platform CosMx + MERSCOPE + Xenium FFPE benchmark bundle on matched FFPE tumor samples with synthetic-construct spike-ins for cross-platform calibration) + AI drug discovery / non-coding target nomination (Hi-C + ATAC + multi-omics bundle dissecting non-coding GWAS loci to causal genes in cardiac + neurological disease) + bioinformatics / precision-oncology (Xenium MIBC spatial atlas surfacing lineage-specific vulnerabilities) — three orthogonal modalities spanning 3 of 6 Brown Biotech coverage categories (biotech infrastructure, AI drug discovery, bioinformatics), all clean-license GEO with raw files available and spanning a balanced combination of freshly indexed methodology bundles (CosMx/MERSCOPE/Xenium + Hi-C) and a precision-oncology spatial atlas; the watcher's 2026-06-30 scan (collected_at 2026-06-29T21:02–21:03 UTC = 2026-06-30 06:02–06:03 KST) ran on its normal 06:00 KST cadence and emitted 105 hits (~72 unique non-digested accessions after de-duplicating against id:23–id:27); the GSE308146/47/48 three-platform FFPE benchmark bundle — previously referenced as a complement in id:22 and id:26's narratives — is today promoted to primary feature to anchor the recurring biotech-infrastructure / spatial-cohort QC thread, and GSE326226 (first referenced in id:22) receives its first primary-feature promotion to anchor the precision-oncology / Xenium-atlas thread. --- ## 🎯 Highlights ### 1. Systematic benchmarking of imaging spatial transcriptomics platforms in FFPE tissues [CosMx] (GSE308146, score 9, n=4, pdat 2025/10/03, single-cell + spatial, Homo sapiens, clean license, raw files, no risk signals, suppfile CSV/RDS) + [MERSCOPE] (GSE308147, score 9, n=6, pdat 2025/10/03, single-cell + spatial, Homo sapiens + synthetic-construct spike-ins, clean license, raw files, no risk signals, suppfile ZIP) + [Xenium] (GSE308148, score 9, n=8, pdat 2025/10/03, single-cell + spatial, Homo sapiens, clean license, raw files, no risk signals, suppfile HTML/JSON/PARQUET/TIFF): freshly indexed score-9 three-platform (CosMx + MERSCOPE + Xenium) systematic-benchmark bundle running on matched FFPE tumor samples with synthetic-construct spike-ins for cross-platform calibration — cleanest possible head-to-head three-platform FFPE harmonization dataset and gold-standard input for Brown Biotech's biotech-infrastructure / spatial-cohort QC pipeline (FFPE is the dominant archival format for clinical oncology samples and cross-platform harmonization is the dominant bottleneck for multi-cohort spatial meta-analyses); previously referenced as a complement in id:22 and id:26's narratives, today promoted to primary feature to anchor the recurring biotech-infrastructure / spatial-cohort QC thread; the n=4 + n=6 + n=8 cohort sizes with synthetic-construct spike-ins in MERSCOPE deliver maximum cross-platform calibration utility and pair directly with the GSE299886 + GSE300007 MERFISH + Xenium FFPE bundle (id:26) on the shared cross-platform-harmonization methodology ### 2. Dissecting Non-Coding GWAS Loci with High-Resolution 3D Chromatin Interactions Reveals Causal Genes with Relevance to Heart and Brain Disease [Hi-C] (GSE281462, score 9, n=4, pdat 2025/06/16, protein-design / 3D-chromatin, Homo sapiens, clean license, raw files, no risk signals, suppfile NARROWPEAK) + [Hi-C HiC] (GSE281463, score 9, n=4, pdat 2025/06/16, Homo sapiens, suppfile HIC) + [RDS] (GSE281464, score 9, n=7, Homo sapiens, suppfile RDS) + [TXT] (GSE281465, score 9, n=3, Homo sapiens, suppfile TXT): freshly indexed score-9 four-dataset Hi-C + ATAC + multi-omics bundle nominating causal genes from non-coding GWAS loci via high-resolution 3D chromatin interactions — the gold-standard variant-to-gene (V2G) dissection design and direct AI drug discovery input for Brown Biotech's non-coding-target nomination lane (non-coding GWAS variants account for >90% of GWAS heritability but the causal V2G mapping problem remains the central bottleneck in human genetics; non-coding regulatory elements are an underexplored target class for small-molecule and CRISPRa/i therapeutics); cardiac + neurological disease relevance positions this as a clean input for the Brown Biotech cardiovascular and neurodegeneration briefs; pairs conceptually with the GSE315246/47/48 FAP-directed atherosclerosis bundle (id:23) on shared cardiovascular-target-prioritization ### 3. A Xenium Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities (GSE326226, score 9, n=5, pdat 2026/05/05, single-cell + spatial, Homo sapiens, clean license, raw files, no risk signals, suppfile CSV/H5/PARQUET/TIFF): freshly deposited (pdat = ~2 months ago) score-9 Xenium spatial atlas of muscle-invasive bladder cancer (MIBC, the most aggressive form of urothelial carcinoma with 5-year survival <30% for advanced disease and limited response to immune checkpoint blockade) surfacing lineage-specific vulnerabilities via spatial transcriptomics — the cleanest possible precision-oncology spatial atlas for urological indications and direct input for Brown Biotech's bioinformatics / precision-oncology and AI drug discovery / spatial-target-validation lanes; pairs with the GSE268014 HPV+/HPV- HNSCC spatial tumor heterogeneity atlas (today, below the fold) and the GSE311507 HNSCC subtype-specific dependency atlas (id:25) on a shared urological/head-neck precision-oncology thread; promoted to primary feature today after first being referenced in id:22's narrative ### 4. Combined signal: biotech infrastructure / spatial-cohort QC (three-platform CosMx + MERSCOPE + Xenium FFPE benchmark bundle on matched FFPE tumor samples with synthetic-construct spike-ins for cross-platform calibration) + AI drug discovery / non-coding target nomination (Hi-C + ATAC + multi-omics bundle dissecting non-coding GWAS loci to causal genes in cardiac + neurological disease) + bioinformatics / precision-oncology (Xenium MIBC spatial atlas surfacing lineage-specific vulnerabilities) — three orthogonal modalities spanning 3 of 6 Brown Biotech coverage categories (biotech infrastructure, AI drug discovery, bioinformatics), all clean-license GEO with raw files available; the watcher's 2026-06-30 scan (collected_at 2026-06-29T21:02–21:03 UTC = 2026-06-30 06:02–06:03 KST) ran on its normal 06:00 KST cadence and emitted 105 hits (~72 unique non-digested accessions after de-duplicating against id:23–id:27); the GSE308146/47/48 three-platform FFPE benchmark bundle — previously referenced as a complement in id:22 and id:26's narratives — is today promoted to primary feature to anchor the recurring biotech-infrastructure / spatial-cohort QC thread, and GSE326226 (first referenced in id:22) receives its first primary-feature promotion to anchor the precision-oncology / Xenium-atlas thread; together with the GSE277080 standardized-metrics methodology atlas (id:25) and the GSE299886 + GSE300007 MERFISH + Xenium FFPE bundle (id:26), today's promotion of GSE308146/47/48 completes the cross-platform FFPE benchmarking trilogy --- ## 💼 Next Steps - **[Request biotech infrastructure / FFPE cross-platform brief](https://brownbio.tech/services/biostatx#brief)** - **[Request AI drug discovery / non-coding GWAS V2G brief](https://brownbio.tech/services/ai-drug-discovery#brief)** - **[Request bioinformatics / MIBC Xenium atlas brief](https://brownbio.tech/multiomics#brief)** - **[View biostatx service](https://brownbio.tech/services/biostatx)** --- ## 📡 Provenance - **Source:** research-watcher (PubMed/GEO scan, 27 query families × Brown Biotech pipelines) - **Pipeline:** [`brown-biotech-daily-tech-digest`](https://github.com/ohbryt/brown-biotech-platform) — 06:00 KST cron - **Generated:** 2026-06-30 06:09 KST - **Repo:** `ohbryt/brown-biotech-platform` --- _Auto-published by `brown_biotech_research_digest_publisher.py` · [brownbio.tech](https://brownbio.tech) · Decision-ready research, daily._
Brown Biotech Research Digest — 2026-06-30
PubMed/GEO scan · research-watcher · 06:00 KST